Abstract
Tocilizumab is an interleukin receptor inhibitor that has been used in patients with COVID-19 pneumonia. There are recent randomized controlled trials (RCTs) that evaluated the efficacy and safety of tocilizumab...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have